{ "ok": true, "cik": "1800373", "ticker": "GWLL", "name": "GOLDENWELL BIOTECH, INC.", "filings": [ { "form": "8-K", "filed": "2026-09-29", "items": [ "4.01 Changes in Registrant's Certifying Accountant", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226005892/0001477932-26-005892-index.htm" }, { "form": "10-Q", "filed": "2026-08-14", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226005067/0001477932-26-005067-index.htm" }, { "form": "10-Q", "filed": "2026-07-01", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226004131/0001477932-26-004131-index.htm" }, { "form": "10-K", "filed": "2026-07-01", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226004130/0001477932-26-004130-index.htm" }, { "form": "8-K", "filed": "2026-05-27", "items": [ "4.02 Non-Reliance on Previously Issued Financial Statements", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226003440/0001477932-26-003440-index.htm" }, { "form": "10-Q", "filed": "2025-12-08", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793225008837/0001477932-25-008837-index.htm" } ], "events12m": 2, "healthWatch": { "window": "last 12 months", "since": "2025-09-30", "signals": [ { "code": "NT 10-K", "label": "Late annual report notice", "count": 1, "latest": { "filed": "2026-03-31", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226001748/0001477932-26-001748-index.htm" } }, { "code": "4.02", "label": "Earlier statements no longer to be relied on", "count": 1, "latest": { "filed": "2026-05-27", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226003440/0001477932-26-003440-index.htm" } }, { "code": "NT 10-Q", "label": "Late quarterly report notice", "count": 1, "latest": { "filed": "2026-05-12", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226002962/0001477932-26-002962-index.htm" } }, { "code": "4.01", "label": "Auditor change", "count": 1, "latest": { "filed": "2026-09-29", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226005892/0001477932-26-005892-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001800373.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1800373" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up GOLDENWELL BIOTECH, INC. ($GWLL). Last filing: 8-K (4.01 Changes in Registrant's Certifying Accountant), 2026-09-29. 2 event filings (8-K) in the past twelve months. Auditor change (8-K Item 4.01) filed 2026-09-29. Non-reliance (8-K Item 4.02) filed 2026-05-27.", "auditor": { "changes": [ { "filed": "2026-09-29", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226005892/0001477932-26-005892-index.htm" }, { "filed": "2025-08-19", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793225006051/0001477932-25-006051-index.htm" }, { "filed": "2025-01-23", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793225000424/0001477932-25-000424-index.htm" }, { "filed": "2024-11-15", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793224007310/0001477932-24-007310-index.htm" } ], "nonReliance": [ { "filed": "2026-05-27", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226003440/0001477932-26-003440-index.htm" } ], "restatedSince": true }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 55, "revenueGrowth1y": -0.60431654676259, "revenueGrowthPerYear": -0.7577382550272354, "yearsOfData": 5, "operatingMargin": -2060.4727272727273, "operatingMarginPrior": -885.5971223021583, "netMargin": -5390.381818181818, "operatingCashFlow": -22629, "capitalSpending": null, "freeCashFlow": null, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 26775, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 15967 }, { "fiscalYearEnd": "2022-12-31", "revenue": 47800 }, { "fiscalYearEnd": "2023-12-31", "revenue": 2340 }, { "fiscalYearEnd": "2024-12-31", "revenue": 139 }, { "fiscalYearEnd": "2025-12-31", "revenue": 55 } ], "totalEquity": -343713, "totalAssets": 36120, "equityRatio": -9.515863787375416, "returnOnEquity": null, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": 0, "sharesOutstanding": 99000000, "bookValuePerShare": -0.0034718484848484847, "revenuePerShare": 5.555555555555555e-7, "range80": { "low": 3.1029401571355217, "high": 60.64710877086102, "baseline": 13.762965270597254, "n": 2483, "band": "b000", "bandLabel": "under $50M", "method": "v4.1", "credibility": 0.25, "growthYears": 2, "ownVolatility": 1.4309311895173253, "classVolatility": 0.3000583276631395, "volatility": 0.7611946316700919 }, "ifPaceHeld": { "low": 3.1029401571355217, "high": 60.64710877086102 } }, "edgarette": "🔖 Exposure: revenue $0K (FY2025). Experience: revenue down 60.4% on the year, down 75.8% a year over 4 years; operating margin -206047.3%, down from -88559.7%. Soundness: equity -951.6% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $0K and $0K next year (method v4.1: its own 2-year record of growth weighed at 25% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $0K to $0K. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, food and kindred products): operating margin -206047.3% against a 7.3% median; growth -60.4% against 4.4%.", "peers": { "sic": 2000, "sicDescription": "Food and Kindred Products", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2000", "growth": [ 0.0437, 10 ], "opMargin": [ 0.0726, 10 ], "equityRatio": [ 0.2609, 9 ] }, "summary": "Goldenwell Biotech (GWLL) saw revenue fall 60.4% in FY2025 to $0 million, operating margin -206047% against a 7.3% median for food and kindred products, equity -952% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
GOLDENWELL BIOTECH, INC. against its own record and its peers
Operating marginPeer median 7.3%-206047.3%Revenue, on the yearPeer median 4.4%-60.4%Equity of assetsPeer median 26.1%-951.6%Gold tick: the median of 9–9 peers with $50M+ revenue in food and kindred products
", "chartHorizon": null, "backtest": { "tests": 1, "hits": 0, "rate": 0, "method": "v4", "byYear": { "2025": [ 0, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-30T14:36:07.820Z", "hash": "d8b4f34a57307f87", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Goldenwell Biotech (GWLL) saw revenue fall 60.4% in FY2025 to $0 million, operating margin -206047% against a 7.3% median for food and kindred products, equity -952% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 55, "totalDebt": null, "cash": 26775 }, "experience": { "revenueGrowth1y": -0.60431654676259, "revenueGrowthPerYear": -0.7577382550272354, "operatingMargin": -2060.4727272727273, "operatingMarginPrior": -885.5971223021583, "netMargin": -5390.381818181818, "freeCashFlow": null }, "soundness": { "equityRatio": -9.515863787375416, "returnOnEquity": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 2000, "sicDescription": "Food and Kindred Products", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2000", "growth": [ 0.0437, 10 ], "opMargin": [ 0.0726, 10 ], "equityRatio": [ 0.2609, 9 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": { "filed": "2026-05-27", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226003440/0001477932-26-003440-index.htm", "restatedSince": true, "markedDown": false }, "auditorChange": { "filed": "2026-09-29", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226005892/0001477932-26-005892-index.htm" } }, "healthWatch": { "window": "last 12 months", "since": "2025-09-30", "signals": [ { "code": "NT 10-K", "label": "Late annual report notice", "count": 1, "latest": { "filed": "2026-03-31", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226001748/0001477932-26-001748-index.htm" } }, { "code": "4.02", "label": "Earlier statements no longer to be relied on", "count": 1, "latest": { "filed": "2026-05-27", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226003440/0001477932-26-003440-index.htm" } }, { "code": "NT 10-Q", "label": "Late quarterly report notice", "count": 1, "latest": { "filed": "2026-05-12", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226002962/0001477932-26-002962-index.htm" } }, { "code": "4.01", "label": "Auditor change", "count": 1, "latest": { "filed": "2026-09-29", "url": "https://www.sec.gov/Archives/edgar/data/1800373/000147793226005892/0001477932-26-005892-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": { "low": 3.1029401571355217, "high": 60.64710877086102, "baseline": 13.762965270597254, "coverage": 0.8, "method": "v4.1", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); width = the company's own volatility of yearly growth, credibility-weighted against its size class (Buhlmann), scaled to the 80% target on 2023 and tested on 2024", "calibratedOn": { "companyYears": 2483, "sizeBand": "under $50M", "fitYears": [ 2018, 2022 ], "tuneYear": 2023, "testYear": 2024, "coverageOnTestYear": 0.8341, "coverageAllYears": 0.6904374799277399, "stressCoverageAllYears": 0.819004992974709, "outcomeYears": [ 2019, 2025 ] }, "credibility": { "weightOnOwnRecord": 0.25, "growthYears": 2, "ownVolatility": 1.4309311895173253, "classVolatility": 0.3000583276631395, "pricedVolatility": 0.7611946316700919, "k": 3 }, "stress": { "low": 2.530694198984711, "high": 74.88951659586209, "basis": "the same range with widths set to hold 80% across 2018-2023, pandemic years included" }, "kind": "a statistical range, not company guidance; no view on the share price", "track": { "backtest": { "tests": 1, "hits": 0, "rate": 0, "method": "v4", "byYear": { "2025": [ 0, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-30T14:36:07.820Z", "hash": "d8b4f34a57307f87", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001800373.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1800373" }, "speedCash": null, "harbor": { "signs": [ { "key": "warning", "text": "filed late annual report notice, earlier statements no longer to be relied on, late quarterly report notice, auditor change in the last 12 months" }, { "key": "balance", "text": "liabilities exceed assets (often from years of share buybacks, not always distress)" }, { "key": "cash", "text": "operating cash flow was negative (-$23K in FY2025)" }, { "key": "range", "text": "revenue is hard to predict: its 80% range is ±90%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 4, "name": "Rotting at the dock", "plain": "four or more warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -22629, "investing": null, "financing": 0, "capitalSpending": null, "free": null, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": -205138, "free": null }, { "fiscalYearEnd": "2022-12-31", "operating": -1072560, "free": null }, { "fiscalYearEnd": "2023-12-31", "operating": -113153, "free": null }, { "fiscalYearEnd": "2024-12-31", "operating": -123077, "free": null }, { "fiscalYearEnd": "2025-12-31", "operating": -22629, "free": null } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 26775, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 36120, "ladder": null, "currentRatio": null, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": null, "harbor": { "signs": [ { "key": "warning", "text": "filed late annual report notice, earlier statements no longer to be relied on, late quarterly report notice, auditor change in the last 12 months" }, { "key": "balance", "text": "liabilities exceed assets (often from years of share buybacks, not always distress)" }, { "key": "cash", "text": "operating cash flow was negative (-$23K in FY2025)" }, { "key": "range", "text": "revenue is hard to predict: its 80% range is ±90%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 4, "name": "Rotting at the dock", "plain": "four or more warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -22629, "investing": null, "financing": 0, "capitalSpending": null, "free": null, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": -205138, "free": null }, { "fiscalYearEnd": "2022-12-31", "operating": -1072560, "free": null }, { "fiscalYearEnd": "2023-12-31", "operating": -113153, "free": null }, { "fiscalYearEnd": "2024-12-31", "operating": -123077, "free": null }, { "fiscalYearEnd": "2025-12-31", "operating": -22629, "free": null } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 26775, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 36120, "ladder": null, "currentRatio": null, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }